Takara Bio (TSE:4974) Inventories, Finished Goods : 円6,784 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Inventories, Finished Goods?

Takara Bio's quarterly finished goods increased from Sep. 2023 (円6,584 Mil) to Dec. 2023 (円7,838 Mil) but then declined from Dec. 2023 (円7,838 Mil) to Mar. 2024 (円6,784 Mil).

Takara Bio's annual finished goods declined from Mar. 2022 (円18,966 Mil) to Mar. 2023 (円6,248 Mil) but then increased from Mar. 2023 (円6,248 Mil) to Mar. 2024 (円6,784 Mil).

Takara Bio Inventories, Finished Goods Historical Data

The historical data trend for Takara Bio's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Inventories, Finished Goods Chart

Takara Bio Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Inventories, Finished Goods

Get a 7-Day Free Trial

4,511.00

4,966.00

18,966.00

6,248.00

6,784.00

Takara Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															6,248.00	6,541.00	6,584.00	7,838.00	6,784.00

Takara Bio Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Takara Bio (TSE:4974) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines